Atlas Trials

Relapsed Neuroblastoma

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed Neuroblastoma

RecordFirmDate
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma (NCT04023331)Clarity Pharmaceuticals Ltd2020-08-18
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) (NCT03635632)Baylor College of Medicine2019-04-23
DNA Vaccination Against Neuroblastoma (NCT04049864)Belarusian Research Center for Pediatric Oncology, Hematology and Immunology2019-01-09
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 (NCT03209869)University of Wisconsin, Madison2018-03-12
Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma (NCT03406273)Giselle Sholler2017-05-01
MIBG for Refractory Neuroblastoma and Pheochromocytoma (NCT01850888)Masonic Cancer Center, University of Minnesota2013-12-01
Parental Decision-Making for Children With Relapsed Neuroblastoma (NCT02282735)Dana-Farber Cancer Institute2013-05-01
A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma (NCT01109238)Giselle Sholler2010-04-01
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma (NCT03649438)University of Texas Southwestern Medical Center

Track Relapsed Neuroblastoma automatically

Every clearance here is in the API, with alerts when new ones post.